|
|
Name: |
Propel Bio Management LLC |
City: |
Los Angeles |
State: |
CA |
Zip: |
90067 |
|
|
|
Achive
data |
View
Filing Period: |
|
|
|
|
|
|
Download |
|
|
|
|
|
Free Registration Required For Full Results
|
|
|
Holdings
Found :
32 |
|
View All Holdings |
Currently
Viewing:
ALL |
|
|
Page 1 of 1 |
Menu
|
Ticker |
Company Name |
Position Rank |
New/Closed Postion |
Last Close |
Value |
Shares Held |
% of Portfolio |
Value Change |
Change In Shares Held |
% of Company |
Industry |
|
PAGP |
Plains Gp Holdings Lp |
1 |
- |
$18.46 |
$21,889,000 |
1,372,360 |
18.15% |
0 |
0 |
0.745 |
Oil & Gas Pipelines &... |
|
APLT |
Applied Therapeutics Inc. |
2 |
- |
$0.00 |
$18,006,000 |
5,374,982 |
14.93% |
0 |
0 |
11.196 |
N/A |
|
TCRX |
Tscan Therapeutics, Inc. |
3 |
- |
$0.00 |
$12,168,000 |
2,087,139 |
10.09% |
0 |
0 |
11.209 |
N/A |
|
MDGL |
Madrigal Pharmaceuticals Inc |
4 |
- |
$205.25 |
$6,949,000 |
30,032 |
5.76% |
0 |
0 |
0.181 |
Diagnostic Substances |
|
CRNX |
Crinetics Pharmaceuticals, ... |
5 |
- |
$48.00 |
$5,871,000 |
165,000 |
4.87% |
0 |
0 |
0.284 |
N/A |
|
FULC |
Fulcrum Therapeutics, Inc. |
6 |
- |
$0.00 |
$5,063,000 |
750,000 |
4.2% |
0 |
0 |
1.19 |
N/A |
|
PHAT |
Phathom Pharmaceuticals, Inc. |
7 |
- |
$0.00 |
$4,045,000 |
443,047 |
3.35% |
0 |
0 |
1.298 |
N/A |
|
DAWN |
Day One Biopharmaceuticals,... |
8 |
- |
$0.00 |
$3,952,000 |
270,664 |
3.28% |
0 |
0 |
0.437 |
N/A |
|
ARDX |
Ardelyx Inc |
9 |
- |
$7.77 |
$3,684,000 |
594,174 |
3.05% |
0 |
0 |
0.499 |
N/A |
|
ATHA |
Athira Pharma, Inc. |
10 |
- |
$0.00 |
$3,627,000 |
1,492,792 |
3.01% |
0 |
0 |
4.844 |
N/A |
|
TSAT |
Telesat Class B Variable Vo... |
11 |
- |
$0.00 |
$3,033,000 |
290,781 |
2.51% |
0 |
0 |
0.646 |
N/A |
|
HIGH |
Simplify Enhanced Income Etf |
12 |
- |
$0.00 |
$2,953,000 |
120,221 |
2.45% |
0 |
0 |
1.336 |
N/A |
|
AKRO |
Akero Therapeutics, Inc. |
13 |
- |
$0.00 |
$2,336,000 |
100,052 |
1.94% |
0 |
0 |
0.199 |
N/A |
|
BSV |
Vanguard Short-Term Bond |
14 |
- |
$76.21 |
$2,134,000 |
27,712 |
1.77% |
0 |
0 |
0.005 |
Closed - End Fund - E... |
|
IBDP |
Ishares Ibonds Dec 2024 Ter... |
15 |
- |
$25.04 |
$2,128,000 |
85,442 |
1.76% |
0 |
0 |
0.022 |
N/A |
|
MBB |
iShares Barclays MBS Bond |
16 |
- |
$90.79 |
$2,107,000 |
22,400 |
1.75% |
0 |
0 |
0.002 |
Closed - End Fund - E... |
|
MIRM |
Mirum Pharmaceuticals, Inc. |
17 |
- |
$0.00 |
$2,066,000 |
70,000 |
1.71% |
0 |
0 |
0.19 |
N/A |
|
MRNS |
Marinus Pharmaceuticals Inc |
18 |
- |
$1.33 |
$1,958,000 |
180,100 |
1.62% |
0 |
0 |
0.363 |
N/A |
|
KURA |
Kura Oncology Inc |
19 |
- |
$20.71 |
$1,869,000 |
130,000 |
1.55% |
0 |
0 |
0.171 |
N/A |
|
RNA |
Avidity Biosciences, Inc. |
20 |
- |
$25.96 |
$1,615,000 |
178,500 |
1.34% |
0 |
0 |
0.224 |
N/A |
|
KYMR |
Kymera Therapeutics, Inc. |
21 |
- |
$0.00 |
$1,435,000 |
56,359 |
1.19% |
0 |
0 |
0.094 |
N/A |
|
SCPB |
Spdr Series Trust Term Corp... |
22 |
- |
$29.61 |
$1,361,000 |
45,695 |
1.13% |
0 |
0 |
0.004 |
Closed - End Fund - Debt |
|
KYN |
Kayne Anderson Mlp Investme... |
23 |
- |
$9.83 |
$1,291,000 |
147,033 |
1.07% |
0 |
0 |
0.116 |
Closed - End Fund - Debt |
|
EIGR |
Eiger BioPharmaceuticals Inc |
24 |
- |
$0.22 |
$986,000 |
4,391,432 |
0.82% |
0 |
0 |
13.5 |
N/A |
|
STRO |
Sutro Biopharma Inc |
25 |
- |
$4.15 |
$837,000 |
195,000 |
0.69% |
0 |
0 |
0.346 |
N/A |
|
SLQD |
iShares 0-5 Year Investment... |
26 |
- |
$49.02 |
$598,000 |
12,148 |
0.5% |
0 |
0 |
0.031 |
N/A |
|
LQD |
iShares Trust Goldman Sachs |
27 |
- |
$106.31 |
$493,000 |
4,456 |
0.41% |
0 |
0 |
0.001 |
Closed - End Fund - E... |
|
XFOR |
X4 Pharmaceuticals Inc |
28 |
- |
$1.05 |
$449,000 |
535,000 |
0.37% |
0 |
0 |
0.773 |
N/A |
|
CYBN |
Cybin Inc |
29 |
- |
$0.36 |
$349,000 |
850,000 |
0.29% |
0 |
0 |
0.536 |
N/A |
|
FLRN |
Spdr Barclays Investment Gr... |
30 |
- |
$30.76 |
$283,000 |
9,267 |
0.23% |
0 |
0 |
0.012 |
N/A |
|
HRTX |
Heron Therapeutics Inc |
31 |
- |
$2.77 |
$177,000 |
104,195 |
0.15% |
0 |
0 |
0.088 |
Synthetics |
|
AGIO |
Agios Pharmaceuticals Inc |
32 |
- |
$33.00 |
$129,000 |
5,792 |
0.11% |
0 |
0 |
0.008 |
N/A |
|